GoodRx.SU - Your Guide to Pharmaceuticals - Page 2
Healthcare System Savings: How Generic Drugs Cut U.S. Drug Costs by Hundreds of Billions
Finnegan O'Sullivan Jan 1 9Generic drugs saved $482 billion in U.S. healthcare spending in 2024, making up 90% of prescriptions but just 12% of costs. Biosimilars are the next frontier in cutting drug prices - if we remove the barriers holding them back.
More Detail
Generic Drug Savings: Real Numbers and National Statistics
Finnegan O'Sullivan Dec 31 11Generic drugs saved $467 billion in the U.S. in 2024 alone - but most people don’t realize how much they’re saving. See the real numbers behind generic vs. brand-name drug costs, biosimilar growth, and why these savings are at risk.
More Detail
Pain and Sleep: How to Break the Insomnia-Pain Cycle for Good
Finnegan O'Sullivan Dec 30 14Chronic pain and insomnia feed each other in a vicious cycle. Learn how sleep loss worsens pain, why pills don't fix it, and how CBT-I is the only proven way to break free-and start sleeping again.
More Detail
Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
Finnegan O'Sullivan Dec 29 9Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product's price. This system affects provider choices, patient costs, and adoption rates.
More Detail
Generational Differences: How Age Shapes Attitudes Toward Generic Medications
Finnegan O'Sullivan Dec 28 12Generational attitudes toward generic medications vary widely-from Baby Boomers who trust brand names to Gen Z who prioritize cost. Learn why age, experience, and health literacy shape perceptions of generic drugs-and how to bridge the trust gap.
More Detail
Non-formulary generics: what to do when coverage is denied
Finnegan O'Sullivan Dec 27 8When your insurance denies coverage for a generic drug, you don't have to pay full price or go without. Learn how to use the legal exceptions process to get your medication covered - with real data, step-by-step guidance, and proven strategies.
More Detail
Bipolar Depression vs. Unipolar Depression: Key Differences in Diagnosis and Treatment
Finnegan O'Sullivan Dec 26 10Bipolar depression and unipolar depression look alike but require completely different treatments. Misdiagnosis leads to dangerous outcomes. Learn how to tell them apart and why the right treatment saves lives.
More Detail
How to Build Patient Confidence in Generic Medications: Proven Strategies Based on Research
Finnegan O'Sullivan Dec 24 12Generic drugs save billions but many patients still distrust them. Learn research-backed ways providers and pharmacists can build confidence through clear, empathetic communication.
More Detail
Market Exclusivity Extensions: How Pharma Companies Extend Monopolies Beyond Patents
Finnegan O'Sullivan Dec 23 12Market exclusivity extensions let pharmaceutical companies delay generic competition long after patents expire, using regulatory tools like orphan drug and pediatric exclusivity. These mechanisms add years to monopolies, costing billions in extra healthcare spending.
More Detail
Mail-Order Pharmacy Cost Savings: Pros and Cons
Finnegan O'Sullivan Dec 22 14Mail-order pharmacies can save hundreds a year on maintenance medications through 90-day supplies and automated systems. Learn the real pros, cons, and who benefits most - plus how to switch without mistakes.
More Detail